Crystal structure of (E)-4-(6-(4-(2-(pyridin-4-yl)vinyl)phenoxy)pyrimidin-4-yl)morpholine, C21H20N4O2-Reference-Cited by-同舟云学术

Crystal structure of (E)-4-(6-(4-(2-(pyridin-4-yl)vinyl)phenoxy)pyrimidin-4-yl)morpholine, C₂₁H₂₀N₄O₂

Published:2022-05-05 Issue:4 Volume:237 Page:583-585
ISSN:1433-7266
Container-title:Zeitschrift für Kristallographie - New Crystal Structures
language:en
Short-container-title:

Author:

Bai Su-Fen¹²,Liu Jia-Xuan¹,Li Shan-Shan¹,Tian Chun-Yu¹,La Xiao-Jin¹

Affiliation:

1. College of Traditional Chinese Medicine , North China University of Science and Technology , 063210 Caofeidian District , Tangshan , P. R. China

2. Department of Basic Medicine , Hebei University of Chinese Medicine , 050091 Qiaoxi District , Shijiazhuang , P. R. China

Abstract

Abstract C21H20N4O2, triclinic, P 1 ‾

$\overline{1}$

(no. 2), a = 5.874(3) Å, b = 16.526(7) Å, c = 20.147(8) Å, α = 67.140(5)°, β = 83.287(6)°, γ = 86.910(6)°, V = 1789.7(14) Å3, Z = 4, Rgt (F) = 0.0614, wRref (F 2) = 0.1675, T = 296 K.

Publisher

Walter de Gruyter GmbH

Subject

Inorganic Chemistry,Condensed Matter Physics,General Materials Science

Link

https://www.degruyter.com/document/doi/10.1515/ncrs-2022-0045/pdf

Reference10 articles.

1. BRUKER. SAINT. Version 8.23B; Bruker AXS Inc.: Madison, Wisconsin, USA, 2013.

2. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.

3. Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. 2008, A64, 112–122; https://doi.org/10.1107/s0108767307043930.

4. Sun, W. J., Hu, S. Q., Fang, S. B., Yan, H. Design, synthesis and biological evaluation of pyrimidine-based derivatives as VEGFR-2 tyrosine kinase inhibitors. Bioorg. Chem. 2018, 22, 393–405; https://doi.org/10.1016/j.bioorg.2018.04.005.

5. Elderfield, R. C. Heterocyclic compounds: six-membered heterocycles containing two hetero atoms and their benzo derivatives. Heterocycl. Compd. 1957, 6, 564–600.